Valuation: Revvity, Inc.

Market Cap 16.97B 85.49B 15.26B 14.24B 12.91B 24.24B 1,615B 24.39B 171B 66.74B 838B 63.73B 62.35B 2,696B P/E 2026 *
64.1x
P/E 2027 * 50.5x
Enterprise Value 18.96B 95.49B 17.05B 15.91B 14.42B 27.07B 1,804B 27.24B 191B 74.55B 936B 71.18B 69.64B 3,012B EV / Sales 2026 *
6.65x
EV / Sales 2027 * 6.13x
Free-Float
99.74%
Yield 2026 *
0.19%
Yield 2027 * 0.18%
1 day+33.98%
1 week+33.98%
Current month+33.98%
1 month+33.98%
3 months+32.56%
6 months+66.57%
Current year+47.59%
1 week 27.47
Extreme 27.47
27.75
1 month 27.47
Extreme 27.47
27.75
Current year 14.91
Extreme 14.91
27.75
1 year 14.91
Extreme 14.91
27.75
3 years 14.51
Extreme 14.51
27.75
5 years 14.51
Extreme 14.51
39.55
10 years 11.96
Extreme 11.957142
39.55
Manager TitleAgeSince
Chief Executive Officer 61 2019-12-29
Director of Finance/CFO 37 2022-09-05
Chief Tech/Sci/R&D Officer - 2023-04-30
Director TitleAgeSince
Chairman 68 2019-12-29
Director/Board Member 74 2012-02-06
Director/Board Member 72 2016-07-26
Change 5-day change 1-year change 3-year change Capi.($)
+33.98%+33.98% - - 17.3B
+1.53%+1.68%+28.03%+39.42% 245B
+0.83%+2.84%+8.99%+7.29% 157B
-0.43%+1.38%-3.70%+53.85% 149B
-0.72%+3.42%-55.32%-13.17% 62.77B
+1.38%+0.78%+17.84%+22.14% 49.15B
+0.38%+3.92%-13.68%-15.68% 49.74B
+1.40%+2.90%+26.05%+57.45% 48.38B
-1.42%+5.26%+3.37%+37.59% 48.84B
+1.73%+0.14%+31.06%+72.84% 42.17B
Average +3.87%+2.65%+4.74%+29.08% 94.66B
Weighted average by Cap. +1.31%+2.53%+8.44%+30.52%

Financials

2026 *2027 *
Net sales 2.85B 14.37B 2.56B 2.39B 2.17B 4.07B 271B 4.1B 28.72B 11.22B 141B 10.71B 10.48B 453B 3.01B 15.15B 2.7B 2.52B 2.29B 4.29B 286B 4.32B 30.29B 11.83B 149B 11.29B 11.05B 478B
Net income 274M 1.38B 246M 230M 208M 391M 26.04B 393M 2.76B 1.08B 13.52B 1.03B 1.01B 43.47B 346M 1.74B 311M 290M 263M 494M 32.94B 497M 3.49B 1.36B 17.1B 1.3B 1.27B 54.99B
Net Debt 1.99B 10B 1.78B 1.67B 1.51B 2.83B 189B 2.85B 19.99B 7.81B 98.05B 7.45B 7.29B 315B 1.46B 7.34B 1.31B 1.22B 1.11B 2.08B 139B 2.09B 14.68B 5.73B 72.03B 5.48B 5.36B 232B
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
152.12USD
Average target price
147.53USD
Spread / Average Target
-3.02%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.